マラリア治療薬市場規模・予測（2020年～2030年）、世界・地域シェア、動向、成長機会分析レポート対象範囲治療薬別（ジェネリック医薬品、先発医薬品、ワクチン、その他）、投与経路別（経口剤、非経口剤）、流通チャネル別（直接入札、病院薬局、小売薬局、オンライン薬局、その他）

Malaria Treatment Market Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Treatment (Generic Drug, Originators, Vaccines, and Others), Route of Administration (Oral and Parenteral), and Distribution Channel (Direct Tender, Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others)

マラリア治療市場は、2022年の32億9,600万米ドルから2030年には244億8,700万米ドルに成長すると予測され、2022年から2030年までの年平均成長率は28.5%と推定される。マラリア治療市場は、低所得国におけるマラリ... もっと見る

出版社	出版年月	電子版価格	ページ数	言語
The Insight Partners ザ・インサイトパートナーズ	2023年11月2日	US$4,550 シングルユーザライセンスライセンス・価格情報注文方法はこちら	320	英語

日本語のページは自動翻訳を利用し作成しています。
実際のレポートは英文のみでご納品いたします。

サマリー

マラリア治療市場は、2022年の32億9,600万米ドルから2030年には244億8,700万米ドルに成長すると予測され、2022年から2030年までの年平均成長率は28.5%と推定される。マラリア治療市場は、低所得国におけるマラリアの高い流行率や、国際機関や国家機関が開始した世界的なマラリア撲滅プログラムによって拡大している。また、先進的な診断ツールの発売が増加し、効果的な治療薬を提供するための研究活動が活発化していることも、市場の成長をさらに後押ししています。しかし、偽造抗マラリア薬やそれに続く薬剤耐性などの要因が市場の成長を抑制しています。

世界保健機関（WHO）の最新の世界マラリア報告（WMR）2020によると、2019年に記録された2億2,700万症例に対し、世界では2億4,100万症例が報告された。同報告書によると、マラリアによる死亡者数は年間6万9000人増加している。これらの死者の約3分の2、すなわち4万7,000人は、COVID-19発生時の医療サービスの混乱が原因であり、残りの3分の1、すなわち2万2,000人は、WHOのマラリア死亡率算出方法の最近の変更を反映したものである（COVID-19の混乱とは無関係）。

WHOアフリカ地域は、マラリアの世界的負担の高い割合を占めている。2020年には、世界の患者数の約95％、死亡者数の約96％がアフリカでマラリアにより報告され、報告された死亡者数全体の約80％が5歳以下の小児であった。WHOによると、ナイジェリア、タンザニア、コンゴ民主共和国、モザンビークのアフリカ4カ国は、世界で報告されたマラリア関連死の約半数を記録した。LANCET Regional Health 2020によると、アフリカ諸国はマラリアの負担が最も大きく、P. falciparumは5歳未満の小児の死亡率が最も高い顕著な原因であり、世界全体で約77％を占めている。アフリカ諸国では、P. falciparumがマラリアによる小児の死亡者全体の約96％を占めている。P.vivaxは、主にアジアで発生したマラリア患者全体の2％（450万人）の原因菌となっている。WMR2021によると、世界のマラリア負担の約2％は東南アジア諸国が占めており、2020年の推定マラリア症例の83％、マラリアに関連する死亡の82％はインドが占めている。このように、世界中のさまざまな地域でマラリアの有病率が上昇していることが、マラリア治療市場の成長を後押ししている。

マラリアの有病率が高い世界中のさまざまな国の政府は、治療オプションを含む医療サービスへのアクセスを改善することによって、この病気を根絶するためにさまざまな戦略を展開しています。実施されているイニシアティブの一部を以下に示す：

- ミャンマーには、世界基金が承認した国家マラリア対策計画があり、2030年までにマラリア原虫による病気を撲滅することが期待されている。同国の国民皆保険制度には、顕微鏡検査や迅速診断検査（RDT）によるマラリア診断、アルテミシニンを主成分とする混合療法（ACT）へのアクセスも含まれている。

- タイ政府は国家マラリア撲滅戦略（NMES）2017-2026を実施し、2024年までにマラリア撲滅を目指す統合的撲滅戦略をさらに適用している。

- 2020年1月、アフリカのマラリアに関する企業同盟（CAMA）は、マラリア対策を通じて数百万人にマラリア感染者を拡大し、アフリカでの予防活動を拡大することを目的とした2021～2023年の戦略計画を開始した。

- このように、マラリア病に対する認識を広めるための上記のイニシアチブは、マラリア治療市場の成長を後押しする撲滅努力を強化するものである。

本レポートでは、マラリア治療市場を以下のように区分している：

治療法に基づき、マラリア治療市場はジェネリック医薬品、オリジネーター、ワクチン、その他に区分される。投与経路に基づき、マラリア治療薬市場は経口剤と非経口剤に区分される。流通チャネル別では、マラリア治療薬市場は直接販売、病院薬局、小売薬局、オンライン薬局、その他に区分される。地域別では、マラリア治療薬市場は北米（米国、カナダ、メキシコ）、欧州（英国、ドイツ、フランス、イタリア、スペイン、その他の欧州）、アジア太平洋地域（中国、日本、インド、オーストラリア、韓国、その他のアジア太平洋地域）に区分される、中東・アフリカ（サウジアラビア、アラブ首長国連邦、南アフリカ、ケニア、タンザニア、ルワンダ、ナイジェリア、ガーナ、ウガンダ、アンゴラ、カメルーン、セネガル、ザンビア、その他の中東・アフリカ地域）、中南米（ブラジル、アルゼンチン、その他の中南米地域）。

治療に基づく洞察

マラリア治療市場は、治療法に基づき、ジェネリック医薬品、オリジネーター、ワクチン、その他に区分される。ワクチン分野が2022年に最大の市場シェアを占めた。ワクチンは、特定の感染症に対する能動的な獲得免疫を提供する。マラリアワクチン市場は、研究開発活動の活発化とワクチン候補のパイプラインの増加により、著しい成長率で伸びている。

投与経路ベースの洞察

投与経路に基づき、マラリア治療薬市場は経口薬と非経口薬・静脈注射薬に二分される。2022年には経口剤セグメントが市場の最大シェアを占めたが、予測期間中は非経口剤セグメントが最も高いCAGRを記録すると予想される。経口薬物送達は、高い患者コンプライアンス、非侵襲性、最小限の無菌性制約、費用対効果、剤形設計の柔軟性、製造プロセスの容易さを提供するため、最も好まれ、薬物投与の適切な経路である。投与の容易さや長期的なコスト効率といった利点は、経口薬の採用を後押しする大きな要因となっている。

流通チャネルに基づく洞察

流通チャネルに基づき、マラリア治療薬市場は直接入札、病院薬局、小売薬局、オンライン薬局、その他に区分される。2022年には、直接入札セグメントが市場の最大シェアを占めたが、予測期間中はオンライン薬局セグメントが最も高いCAGRを記録すると予想される。経口薬物送達は、高い患者コンプライアンス、非侵襲性、最小限の無菌性制約、費用対効果、剤形設計の柔軟性、製造プロセスの容易さを提供するため、最も好まれ、薬物投与の適切な経路である。投与の容易さや長期的なコスト効率といった利点は、経口薬の採用を後押しする大きな要因となっている。

マラリア治療薬市場に関する報告書作成にあたり参照した主な一次および二次情報源としては、世界保健機関（WHO）、米国国勢調査局、CDCなどがある。

ページTOPに戻る

TABLE OF CONTENTS

1. Introduction
1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights - Malaria
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Malaria Treatment Market Landscape
4.1 Overview
4.2 PEST Analysis – Malaria Treatment
5. Malaria Treatment Market - Key Industry Dynamics
5.1 Key Market Drivers:
5.1.1 Increasing Prevalence of Malaria
5.1.2 Rising Initiatives to Raise Awareness about Malaria
5.2 Market Restraints
5.2.1 Availability of Counterfeit Antimalarial Drugs Followed by Subsequent Drug Resistance
5.3 Market Opportunities
5.3.1 Growing Strategic Initiatives by Market Players
5.4 Future Trends
5.4.1 Extending Pipeline of New Drugs and Vaccines
5.5 Impact Analysis
6. Malaria Treatment Market - Global Market Analysis
6.1 Malaria Treatment Market Revenue (US$ million), 2022 – 2030
6.2 Geography Analysis Market Revenue (US$ million), 2022 – 2030
7. Malaria Treatment Market – Revenue and Forecast to 2030 – by Treatment
7.1 Overview
7.2 Malaria Treatment Market Revenue Share, by Treatment 2022 & 2030 (%)
7.3 Vaccines
7.3.1 Overview
7.3.2 Vaccines Market Revenue and Forecast to 2028 (US$ Mn)
7.4 Generic Drugs
7.4.1 Overview
7.4.2 Generic Drugs Market Revenue and Forecast to 2028 (US$ Mn)
7.5 Originators
7.5.1 Overview
7.5.2 Originators Market Revenue and Forecast to 2028 (US$ Mn)
7.6 Others
7.6.1 Overview
7.6.2 Others Market Revenue and Forecast to 2028 (US$ Mn)
8. Malaria Treatment Market – Revenue and Forecast to 2030 – by Route of Administration
8.1 Overview
8.2 Malaria Treatment Market Revenue Share, by Route of Administration 2022 & 2030 (%)
8.3 Oral
8.3.1 Overview
8.3.2 Oral: Malaria Treatment Market – Revenue and Forecast to 2030 (US$ Million)
8.4 Parenteral
8.4.1 Overview
8.4.2 Parenteral: Malaria Treatment Market – Revenue and Forecast to 2030 (US$ Million)
9. Malaria Treatment Market – Revenue and Forecast to 2030 – by Distribution Channel
9.1 Overview
9.2 Malaria Treatment Market Revenue Share, by Distribution Channel 2022 & 2030 (%)
9.3 Direct Tender
9.3.1 Overview
9.3.2 Direct Tender: Malaria Treatment Market – Revenue and Forecast to 2030 (US$ Million)
9.4 Hospital Pharmacies
9.4.1 Overview
9.4.2 Hospital Pharmacies: Malaria Market – Revenue and Forecast to 2030 (US$ Million)
9.4.2.1.1 Malaria Treatment Market, by Hospital Pharmacies
9.5 Retail Pharmacies
9.5.1 Overview
9.5.2 Retail Pharmacies: Malaria Treatment Market – Revenue and Forecast to 2030 (US$ Million)
9.5.2.1.1 Malaria Treatment Market, by Retail Pharmacies
9.6 Online Pharmacies
9.6.1 Overview
9.6.2 Online Pharmacies: Malaria Treatment Market – Revenue and Forecast to 2030 (US$ Million)
9.7 Others
9.7.1 Overview
9.7.2 Others : Malaria Treatment Market – Revenue and Forecast to 2030 (US$ Million)
10. Malaria Treatment Market - Geographical Analysis
10.1 North America Malaria Treatment Market, Revenue and Forecast To 2030
10.1.1 Overview
10.1.2 Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
10.1.2.1 North America: Malaria Treatment Market, by Treatment
10.1.2.2 North America: Malaria Treatment Market, by Route of Administration
10.1.2.3 North America: Malaria Treatment Market, by Distribution Channel
10.1.2.3.1 North America: Malaria Treatment Market, by Hospital Pharmacies
10.1.2.3.2 North America: Malaria Treatment Market, by Retail Pharmacies
10.1.2.4 North America: Malaria Treatment Market, by Country
10.1.2.5 US
10.1.2.6 Overview
10.1.2.6.1 US: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
10.1.2.6.2 US: Malaria Treatment Market, by Treatment
10.1.2.6.3 US: Malaria -Malaria Treatment Market, by Route of Administration
10.1.2.6.4 US: Malaria Treatment Market, by Distribution Channel
10.1.2.6.4.1 US: Malaria Treatment Market, by Hospital Pharmacies
10.1.2.6.4.2 US: Malaria Treatment Market, by Retail Pharmacies
10.1.2.7 Canada
10.1.2.8 Overview
10.1.2.8.1 Canada: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
10.1.2.8.2 Canada: Malaria Treatment Market, by Treatment
10.1.2.8.3 Canada: Malaria -Malaria Treatment Market, by Route of Administration
10.1.2.8.4 Canada: Malaria Treatment Market, by Distribution Channel
10.1.2.8.4.1 Canada: Malaria Treatment Market, by Hospital Pharmacies
10.1.2.8.4.2 Canada: Malaria Treatment Market, by Retail Pharmacies
10.1.2.9 Mexico
10.1.2.10 Overview
10.1.2.10.1 Mexico: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
10.1.2.10.2 Mexico: Malaria Treatment Market, by Treatment
10.1.2.10.3 Mexico: Malaria -Malaria Treatment Market, by Route of Administration
10.1.2.10.4 Mexico: Malaria Treatment Market, by Distribution Channel
10.1.2.10.4.1 Mexico: Malaria Treatment Market, by Hospital Pharmacies
10.1.2.10.4.2 Mexico: Malaria Treatment Market, by Retail Pharmacies
10.2 Europe Malaria Treatment Market, Revenue and Forecast To 2030
10.2.1 Overview
10.2.2 Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
10.2.2.1 Europe: Malaria Treatment Market, by Treatment
10.2.2.2 Europe: Malaria Treatment Market, by Route of Administration
10.2.2.3 Europe: Malaria Treatment Market, by Distribution Channel
10.2.2.3.1 Europe: Malaria Treatment Market, by Hospital Pharmacies
10.2.2.3.2 Europe: Malaria Treatment Market, by Retail Pharmacies
10.2.2.4 Europe: Malaria Treatment Market, by Countries
10.2.2.5 France
10.2.2.6 Overview
10.2.2.6.1 France: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
10.2.2.6.2 France: Malaria Treatment Market, by Treatment
10.2.2.6.3 France: Malaria -Malaria Treatment Market, by Route of Administration
10.2.2.6.4 France: Malaria Treatment Market, by Distribution Channel
10.2.2.6.4.1 France: Malaria Treatment Market, by Hospital Pharmacies
10.2.2.6.4.2 France: Malaria Treatment Market, by Retail Pharmacies
10.2.2.7 UK
10.2.2.8 Overview
10.2.2.8.1 UK: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
10.2.2.8.2 UK: Malaria Treatment Market, by Treatment
10.2.2.8.3 UK: Malaria -Malaria Treatment Market, by Route of Administration
10.2.2.8.4 UK: Malaria Treatment Market, by Distribution Channel
10.2.2.8.4.1 UK: Malaria Treatment Market, by Hospital Pharmacies
10.2.2.8.4.2 UK: Malaria Treatment Market, by Retail Pharmacies
10.2.2.9 Italy
10.2.2.10 Overview
10.2.2.10.1 Italy: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
10.2.2.10.2 Italy: Malaria Treatment Market, by Treatment
10.2.2.10.3 Italy: Malaria -Malaria Treatment Market, by Route of Administration
10.2.2.10.4 Italy: Malaria Treatment Market, by Distribution Channel
10.2.2.10.4.1 Italy: Malaria Treatment Market, by Hospital Pharmacies
10.2.2.10.4.2 Italy: Malaria Treatment Market, by Retail Pharmacies
10.2.2.11 Germany
10.2.2.12 Overview
10.2.2.12.1 Germany: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
10.2.2.12.2 Germany: Malaria Treatment Market, by Treatment
10.2.2.12.3 Germany: Malaria -Malaria Treatment Market, by Route of Administration
10.2.2.12.4 Germany: Malaria Treatment Market, by Distribution Channel
10.2.2.12.4.1 Germany: Malaria Treatment Market, by Hospital Pharmacies
10.2.2.12.4.2 Germany: Malaria Treatment Market, by Retail Pharmacies
10.2.2.13 Spain
10.2.2.14 Overview
10.2.2.14.1 Spain: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
10.2.2.14.2 Spain: Malaria Treatment Market, by Treatment
10.2.2.14.3 Spain: Malaria -Malaria Treatment Market, by Route of Administration
10.2.2.14.4 Spain: Malaria Treatment Market, by Distribution Channel
10.2.2.14.4.1 Spain: Malaria Treatment Market, by Hospital Pharmacies
10.2.2.14.4.2 Spain: Malaria Treatment Market, by Retail Pharmacies
10.2.2.15 Rest of Europe
10.2.2.16 Overview
10.2.2.16.1 Rest of Europe: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
10.2.2.16.2 Rest of Europe: Malaria Treatment Market, by Treatment
10.2.2.16.3 Rest of Europe: Malaria -Malaria Treatment Market, by Route of Administration
10.2.2.16.4 Rest of Europe: Malaria Treatment Market, by Distribution Channel
10.2.2.16.4.1 Rest of Europe: Malaria Treatment Market, by Hospital Pharmacies
10.2.2.16.4.2 Rest of Europe: Malaria Treatment Market, by Retail Pharmacies
10.3 Asia Pacific Malaria Treatment Market, Revenue and Forecast To 2030
10.3.1 Overview
10.3.2 Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
10.3.2.1 Asia Pacific: Malaria Treatment Market, by Treatment
10.3.2.2 Asia Pacific: Malaria Treatment Market, by Route of Administration
10.3.2.3 Asia Pacific: Malaria Treatment Market, by Distribution Channel
10.3.2.3.1 Asia Pacific: Malaria Treatment Market, by Hospital Pharmacies
10.3.2.3.2 Asia Pacific: Malaria Treatment Market, by Retail Pharmacies
10.3.2.4 Asia Pacific: Malaria Treatment Market, by Countries
10.3.2.5 Japan
10.3.2.6 Overview
10.3.2.6.1 Japan: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
10.3.2.6.2 Japan: Malaria Treatment Market, by Treatment
10.3.2.6.3 Japan: Malaria -Malaria Treatment Market, by Route of Administration
10.3.2.6.4 Japan: Malaria Treatment Market, by Distribution Channel
10.3.2.6.4.1 Japan: Malaria Treatment Market, by Hospital Pharmacies
10.3.2.6.4.2 Japan: Malaria Treatment Market, by Retail Pharmacies
10.3.2.7 India
10.3.2.8 Overview
10.3.2.8.1 India: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
10.3.2.8.2 India: Malaria Treatment Market, by Treatment
10.3.2.8.3 India: Malaria -Malaria Treatment Market, by Route of Administration
10.3.2.8.4 India: Malaria Treatment Market, by Distribution Channel
10.3.2.8.4.1 India: Malaria Treatment Market, by Hospital Pharmacies
10.3.2.8.4.2 India: Malaria Treatment Market, by Retail Pharmacies
10.3.2.9 South Korea
10.3.2.10 Overview
10.3.2.10.1 South Korea: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
10.3.2.10.2 South Korea: Malaria Treatment Market, by Treatment
10.3.2.10.3 South Korea: Malaria -Malaria Treatment Market, by Route of Administration
10.3.2.10.4 South Korea: Malaria Treatment Market, by Distribution Channel
10.3.2.10.4.1 South Korea: Malaria Treatment Market, by Hospital Pharmacies
10.3.2.10.4.2 South Korea: Malaria Treatment Market, by Retail Pharmacies
10.3.2.11 Australia
10.3.2.12 Overview
10.3.2.12.1 Australia: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
10.3.2.12.2 Australia: Malaria Treatment Market, by Treatment
10.3.2.12.3 Australia: Malaria -Malaria Treatment Market, by Route of Administration
10.3.2.12.4 Australia: Malaria Treatment Market, by Distribution Channel
10.3.2.12.4.1 Australia: Malaria Treatment Market, by Hospital Pharmacies
10.3.2.12.4.2 Australia: Malaria Treatment Market, by Retail Pharmacies
10.3.2.13 Rest of Asia Pacific
10.3.2.14 Overview
10.3.2.14.1 Rest of Asia Pacific: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
10.3.2.14.2 Rest of Asia Pacific: Malaria Treatment Market, by Treatment
10.3.2.14.3 Rest of Asia Pacific: Malaria -Malaria Treatment Market, by Route of Administration
10.3.2.14.4 Rest of Asia Pacific: Malaria Treatment Market, by Distribution Channel
10.3.2.14.4.1 Rest of Asia Pacific: Malaria Treatment Market, by Hospital Pharmacies
10.3.2.14.4.2 Rest of Asia Pacific: Malaria Treatment Market, by Retail Pharmacies
10.4 Middle East & Africa Malaria Treatment Market, Revenue and Forecast To 2030
10.4.1 Overview
10.4.2 Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
10.4.2.1 Middle East & Africa: Malaria Treatment Market, by Treatment
10.4.2.2 Middle East & Africa: Malaria Treatment Market, by Route of Administration
10.4.2.3 Middle East & Africa: Malaria Treatment Market, by Distribution Channel
10.4.2.3.1 Middle East & Africa: Malaria Treatment Market, by Hospital Pharmacies
10.4.2.3.2 Middle East & Africa: Malaria Treatment Market, by Retail Pharmacies
10.4.2.4 Middle East & Africa: Malaria Treatment Market, by Country
10.4.2.5 Saudi Arabia
10.4.2.6 Overview
10.4.2.6.1 Saudi Arabia: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
10.4.2.6.2 Saudi Arabia: Malaria Treatment Market, by Treatment
10.4.2.6.3 Saudi Arabia: Malaria -Malaria Treatment Market, by Route of Administration
10.4.2.6.4 Saudi Arabia: Malaria Treatment Market, by Distribution Channel
10.4.2.6.4.1 Saudi Arabia: Malaria Treatment Market, by Hospital Pharmacies
10.4.2.6.4.2 Saudi Arabia: Malaria Treatment Market, by Retail Pharmacies
10.4.2.7 UAE
10.4.2.8 Overview
10.4.2.8.1 UAE: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
10.4.2.8.2 UAE: Malaria Treatment Market, by Treatment
10.4.2.8.3 UAE: Malaria -Malaria Treatment Market, by Route of Administration
10.4.2.8.4 UAE: Malaria Treatment Market, by Distribution Channel
10.4.2.8.4.1 UAE: Malaria Treatment Market, by Hospital Pharmacies
10.4.2.8.4.2 UAE: Malaria Treatment Market, by Retail Pharmacies
10.4.2.9 South Africa
10.4.2.10 Overview
10.4.2.10.1 South Africa: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
10.4.2.10.2 South Africa: Malaria Treatment Market, by Treatment
10.4.2.10.3 South Africa: Malaria -Malaria Treatment Market, by Route of Administration
10.4.2.10.4 South Africa: Malaria Treatment Market, by Distribution Channel
10.4.2.10.4.1 South Africa: Malaria Treatment Market, by Hospital Pharmacies
10.4.2.10.4.2 South Africa: Malaria Treatment Market, by Retail Pharmacies
10.4.2.11 Kenya
10.4.2.12 Overview
10.4.2.12.1 Kenya: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
10.4.2.12.2 Kenya: Malaria Treatment Market, by Treatment
10.4.2.12.3 Kenya: Malaria -Malaria Treatment Market, by Route of Administration
10.4.2.12.4 Kenya: Malaria Treatment Market, by Distribution Channel
10.4.2.12.4.1 Kenya: Malaria Treatment Market, by Hospital Pharmacies
10.4.2.12.4.2 Kenya: Malaria Treatment Market, by Retail Pharmacies
10.4.2.13 Tanzania
10.4.2.14 Overview
10.4.2.14.1 Tanzania: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
10.4.2.14.2 Tanzania: Malaria Treatment Market, by Treatment
10.4.2.14.3 Tanzania: Malaria -Malaria Treatment Market, by Route of Administration
10.4.2.14.4 Tanzania: Malaria Treatment Market, by Distribution Channel
10.4.2.14.4.1 Tanzania: Malaria Treatment Market, by Hospital Pharmacies
10.4.2.14.4.2 Tanzania: Malaria Treatment Market, by Retail Pharmacies
10.4.2.15 Rwanda
10.4.2.16 Overview
10.4.2.16.1 Rwanda: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
10.4.2.16.2 Rwanda: Malaria Treatment Market, by Treatment
10.4.2.16.3 Rwanda: Malaria -Malaria Treatment Market, by Route of Administration
10.4.2.16.4 Rwanda: Malaria Treatment Market, by Distribution Channel
10.4.2.16.4.1 Rwanda: Malaria Treatment Market, by Hospital Pharmacies
10.4.2.16.4.2 Rwanda: Malaria Treatment Market, by Retail Pharmacies
10.4.2.17 Nigeria
10.4.2.18 Overview
10.4.2.18.1 Nigeria: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
10.4.2.18.2 Nigeria: Malaria Treatment Market, by Treatment
10.4.2.18.3 Nigeria: Malaria -Malaria Treatment Market, by Route of Administration
10.4.2.18.4 Nigeria: Malaria Treatment Market, by Distribution Channel
10.4.2.18.4.1 Nigeria: Malaria Treatment Market, by Hospital Pharmacies
10.4.2.18.4.2 Nigeria: Malaria Treatment Market, by Retail Pharmacies
10.4.2.19 Ghana
10.4.2.20 Overview
10.4.2.20.1 Ghana: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
10.4.2.20.2 Ghana: Malaria Treatment Market, by Treatment
10.4.2.20.3 Ghana: Malaria -Malaria Treatment Market, by Route of Administration
10.4.2.20.4 Ghana: Malaria Treatment Market, by Distribution Channel
10.4.2.20.4.1 Ghana: Malaria Treatment Market, by Hospital Pharmacies
10.4.2.20.4.2 Ghana: Malaria Treatment Market, by Retail Pharmacies
10.4.2.21 Uganda
10.4.2.22 Overview
10.4.2.22.1 Uganda: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
10.4.2.22.2 Uganda: Malaria Treatment Market, by Treatment
10.4.2.22.3 Uganda: Malaria -Malaria Treatment Market, by Route of Administration
10.4.2.22.4 Uganda: Malaria Treatment Market, by Distribution Channel
10.4.2.22.4.1 Uganda: Malaria Treatment Market, by Hospital Pharmacies
10.4.2.22.4.2 Uganda: Malaria Treatment Market, by Retail Pharmacies
10.4.2.23 Angola
10.4.2.24 Overview
10.4.2.24.1 Angola: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
10.4.2.24.2 Angola: Malaria Treatment Market, by Treatment
10.4.2.24.3 Angola: Malaria -Malaria Treatment Market, by Route of Administration
10.4.2.24.4 Angola: Malaria Treatment Market, by Distribution Channel
10.4.2.24.4.1 Angola: Malaria Treatment Market, by Hospital Pharmacies
10.4.2.24.4.2 Angola: Malaria Treatment Market, by Retail Pharmacies
10.4.2.25 Cameroon
10.4.2.26 Overview
10.4.2.26.1 Cameroon: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
10.4.2.26.2 Cameroon: Malaria Treatment Market, by Treatment
10.4.2.26.3 Cameroon: Malaria -Malaria Treatment Market, by Route of Administration
10.4.2.26.4 Cameroon: Malaria Treatment Market, by Distribution Channel
10.4.2.26.4.1 Cameroon: Malaria Treatment Market, by Hospital Pharmacies
10.4.2.26.4.2 Cameroon: Malaria Treatment Market, by Retail Pharmacies
10.4.2.27 Senegal
10.4.2.28 Overview
10.4.2.28.1 Senegal: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
10.4.2.28.2 Senegal: Malaria Treatment Market, by Treatment
10.4.2.28.3 Senegal: Malaria -Malaria Treatment Market, by Route of Administration
10.4.2.28.4 Senegal: Malaria Treatment Market, by Distribution Channel
10.4.2.28.4.1 Senegal: Malaria Treatment Market, by Hospital Pharmacies
10.4.2.28.4.2 Senegal: Malaria Treatment Market, by Retail Pharmacies
10.4.2.29 Zambia
10.4.2.30 Overview
10.4.2.30.1 Zambia: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
10.4.2.30.2 Zambia: Malaria Treatment Market, by Treatment
10.4.2.30.3 Zambia: Malaria -Malaria Treatment Market, by Route of Administration
10.4.2.30.4 Zambia: Malaria Treatment Market, by Distribution Channel
10.4.2.30.4.1 Zambia: Malaria Treatment Market, by Hospital Pharmacies
10.4.2.30.4.2 Zambia: Malaria Treatment Market, by Retail Pharmacies
10.4.2.31 Rest of Middle East & Africa
10.4.2.32 Overview
10.4.2.32.1 Rest of Middle East & Africa: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
10.4.2.32.2 Rest of Middle East & Africa: Malaria Treatment Market, by Treatment
10.4.2.32.3 Rest of Middle East & Africa: Malaria -Malaria Treatment Market, by Route of Administration
10.4.2.32.4 Rest of Middle East & Africa: Malaria Treatment Market, by Distribution Channel
10.4.2.32.4.1 Rest of Middle East & Africa: Malaria Treatment Market, by Hospital Pharmacies
10.4.2.32.4.2 Rest of Middle East & Africa: Malaria Treatment Market, by Retail Pharmacies
10.5 South & Central America Malaria Treatment Market, Revenue and Forecast To 2030
10.5.1 Overview
10.5.2 Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
10.5.2.1 South & Central America: Malaria Treatment Market, by Treatment
10.5.2.2 South & Central America: Malaria Treatment Market, by Route of Administration
10.5.2.3 South & Central America: Malaria Treatment Market, by Distribution Channel
10.5.2.3.1 South & Central America: Malaria Treatment Market, by Hospital Pharmacies
10.5.2.3.2 South & Central America: Malaria Treatment Market, by Retail Pharmacies
10.5.2.4 South & Central America: Malaria Treatment Market, by Countries
10.5.2.5 Brazil
10.5.2.6 Overview
10.5.2.6.1 Brazil: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
10.5.2.6.2 Brazil: Malaria Treatment Market, by Treatment
10.5.2.6.3 Brazil: Malaria -Malaria Treatment Market, by Route of Administration
10.5.2.6.4 Brazil: Malaria Treatment Market, by Distribution Channel
10.5.2.6.4.1 Brazil: Malaria Treatment Market, by Hospital Pharmacies
10.5.2.6.4.2 Brazil: Malaria Treatment Market, by Retail Pharmacies
10.5.2.7 Argentina
10.5.2.8 Overview
10.5.2.9 Rest of South & Central America
10.5.2.10 Overview
10.5.2.10.1 Rest of South & Central America: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
10.5.2.10.2 Rest of South & Central America: Malaria Treatment Market, by Treatment
10.5.2.10.3 Rest of South & Central America: Malaria -Malaria Treatment Market, by Route of Administration
10.5.2.10.4 Rest of South & Central America: Malaria Treatment Market, by Distribution Channel
10.5.2.10.4.1 Rest of South & Central America: Malaria Treatment Market, by Hospital Pharmacies
10.5.2.10.4.2 Rest of South & Central America: Malaria Treatment Market, by Retail Pharmacies
11. Malaria Treatment Market Industry Landscape
11.1 Overview
11.2 Growth Strategies in the Malaria Treatment Market
11.3 Inorganic Growth Strategies
11.3.1 Overview
11.4 Organic Growth Strategies
11.4.1 Overview
12. Company Profiles
12.1 Cipla Ltd
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Sun Pharmaceutical Industries Ltd
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Sanofi SA
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 GSK Plc
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Novartis AG
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 Pfizer Inc
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Service
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 AdvaCare Pharma USA LLC
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 VLP Therapeutics LLC
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments
12.9 Lupin Ltd
12.9.1 Key Facts
12.9.2 Business Description
12.9.3 Products and Services
12.9.4 Financial Overview
12.9.5 SWOT Analysis
12.9.6 Key Developments
13. Appendix
13.1 About Us
13.2 Glossary of Terms
14. Appendix

ページTOPに戻る

Table of Contents

Summary

The malaria treatment market is expected to grow from US$ 3.296 billion in 2022 to US$ 24.487 billion by 2030; it is estimated to grow at a CAGR of 28.5% from 2022 to 2030. The market for malaria treatment is growing due to the high prevalence of malaria in low-income countries and global malaria elimination programs initiated by international and national organizations. Also, the increasing number of launches of advanced diagnostic tools and rising research activities to provide effective therapeutics are further driving the growth of the market. However, factors such as a counterfeit antimalarial drug and subsequent drug resistance are restraining the market growth.

According to the latest World Malaria Report (WMR) 2020 from the World Health Organization (WHO), 241 million cases of malaria were reported in the world, in comparison to 227 million cases that were logged in 2019. According to the same source, the number of deaths caused due to malaria has an annual rise of 69,000 deaths. Approximately two-thirds of these deaths, i.e., 47,000, were caused by disruptions in healthcare services during the COVID-19 outbreak; the remaining one-third of deaths, i.e., 22,000 reflected a recent change in the WHO’s methodology for calculating malaria mortality (irrespective of COVID-19 disruptions).

The WHO African region accounted for a high share of the global burden of malaria. In 2020, ~95% of global cases and ~96% of deaths were reported in Africa due to malaria, and ~80% of the total deaths that were reported were in children aged 5 and below. According to the WHO, four African countries, Nigeria, Tanzania, the Democratic Republic of the Congo, and Mozambique, recorded approximately half of all malaria-related deaths that were reported globally. According to the LANCET Regional Health 2020, African countries had the highest burden of malaria; P. falciparum is a notable cause of the highest mortality rates in children younger than 5, which accounts for ∼77% across the world; in African countries, P. falciparum accounts for ∼96% of total mortalities caused among children by malaria. P. vivax has been a causal agent of 2% (4.5 million) of the total cases of malaria, mainly from Asia. According to WMR 2021, ∼2% of the global burden of malaria was recorded by Southeast Asian countries, where India accounted for 83% of estimated malaria cases and 82% of deaths associate with malaria in 2020. Thus, the rising prevalence of malaria in different regions across the globe boosts the malaria treatment market growth.

Governments of various countries across the globe with a high prevalence of malaria are deploying various strategies to eradicate the disease by improving access to healthcare services, including treatment options, to the people. A few of the initiatives undertaken are as follows:

• Myanmar has a national malaria control plan that the Global Fund has approved, and by 2030, it is expected to eliminate the disease caused by P. falciparum. The universal healthcare coverage in the country also includes access to malaria diagnosis by means of microscopy or rapid diagnostic tests (RDTs) and artemisinin-based combination therapies (ACTs).

• The government of Thailand has implemented a National Malaria Elimination Strategy (NMES) 2017–2026 that further applies an integrated elimination strategy that aims to eradicate the disease by 2024.

• In January 2020, the Corporate Alliance on Malaria in Africa (CAMA) launched a strategic plan for 2021–2023 with an aim to reach millions of people through malaria control interventions and thereby scale up prevention activities in Africa.

• Thus, the abovementioned initiatives to spread awareness about malaria disease reinforce the eradication efforts to bolster the malaria treatment market growth.

The report segments the malaria treatment market as follows:

Based on treatment, the malaria treatment market is segmented into generic drugs, originators, vaccines, and others. Based on route of administration, the malaria treatment market is divided into oral and parenteral. Based on distribution channel, the malaria treatment market is segmented into direct tender, hospital pharmacies, retail pharmacies, online pharmacies, and others. By geography, the malaria treatment market is segmented into North America (the US, Canada, and Mexico), Europe (the UK, Germany, France, Italy, Spain, and Rest of Europe), Asia Pacific (China, Japan, India, Australia, South Korea, and Rest of Asia Pacific), the Middle East & Africa (Saudi Arabia, the UAE, South Africa, Kenya, Tanzania, Rwanda, Nigeria, Ghana, Uganda, Angola, Cameroon, Senegal, Zambia, and Rest of the Middle East & Africa), and South & Central America (Brazil, Argentina, and Rest of South & Central America).

Treatment-Based Insights

The malaria treatment market is segmented based on treatment into generic drugs, originators, vaccines, and others. vaccines segment held the largest market share in 2022. Vaccines provide active acquired immunity against particular infectious disease. The market for malaria vaccines is growing at a significant growth rate owing to increasing research and development activities and increasing pipeline of vaccine candidates.

Route of Administration-Based Insights

Based on route of administration, the malaria treatment market is bifurcated into oral and parenteral & intravenous. The oral segment accounted for the largest share of the market in 2022; however, the parenteral segment is expected to register the highest CAGR during the forecast period. Oral drug delivery is the most preferred and suitable route of drug administration as it offers high patient compliance, non-invasiveness, least sterility constraints, cost-effectiveness, flexibility in the design of dosage form and ease in the manufacturing process. Benefits such as ease of administration and long-term cost efficiency are major factors fueling the adoption of oral drugs.

Distribution Channel-Based Insights

Based on distribution channels, the malaria treatment market is segmented into direct tender, hospital pharmacies, retail pharmacies, online pharmacies, and others. The direct tender segment accounted for the largest share of the market in 2022; however, the online pharmacies segment is expected to register the highest CAGR during the forecast period. Oral drug delivery is the most preferred and suitable route of drug administration as it offers high patient compliance, non-invasiveness, least sterility constraints, cost-effectiveness, flexibility in the design of dosage form and ease in the manufacturing process. Benefits such as ease of administration and long-term cost efficiency are major factors fueling the adoption of oral drugs.

A few of the major primary and secondary sources referred to while preparing the report on the malaria treatment market are the World Health Organization (WHO), the US Census Bureau, and CDC, among others.

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野（医薬）の最新刊レポート

The Insight Partners社の製薬分野での最新刊レポート

本レポートと同じKEY WORD（generic）の最新刊レポート

よくあるご質問

The Insight Partners社はどのような調査会社ですか?

The Insight Partnersはインドに本社を置く調査会社です。経験豊富な専門家チームを通じて、お客様に最適な調査と分析を提供することに専念しています。幅広い分野をカバーしていますがヘルスケ... もっと見る

調査レポートの納品までの日数はどの程度ですか?

在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。

注文の手続きはどのようになっていますか?

1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。

お支払方法の方法はどのようになっていますか?

納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
お客様よりデータリソース社へ（通常は円払い）の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。

データリソース社はどのような会社ですか?

当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。

サマリー

目次

Summary

Table of Contents

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

本レポートと同分野（医薬）の最新刊レポート

The Insight Partners社の製薬分野での最新刊レポート

本レポートと同じKEY WORD（generic）の最新刊レポート

よくあるご質問

The Insight Partners社はどのような調査会社ですか?

調査レポートの納品までの日数はどの程度ですか?

注文の手続きはどのようになっていますか?

お支払方法の方法はどのようになっていますか?

データリソース社はどのような会社ですか?